Product Details

Product main information:

Product Name: Melanotan I / MT1 / MTI
CAS NO.: 75921-69-6
MF.: C78H111N21O19
MW.: 1646.85

Grade Standard: Pharmacy Grade

Certification: HPLC/MS

Appearance: white power

Place of Origin: China (Mainland)

Min order:1kit

Shelf Date:24 months

Storage temperature: 2-8 Celsius degree

Specification: 10mg/vial 10vials/kit

Purity:99%

Packaging: Bubble/ aluminum foil bag/ box

Shipping Method:EMS,DHL,UPS,TNT or FEDEX

Delivery TIme: 1working day after receive the payment

Arrive Time:4-7 days

Payment Method: Western Union, MoneyGram,  Bank Transfer and paypal.

Keywords:MT1,MTI,Melanotan I,Peptides Melanotan I,MT1 price,MT110mg/vial,Best selling MT1,CAS NO.: 75921-69-6,Peptides
USP Grade, GMP Standard
Function: Through the formation of the melanin, thus reducing the deposits of melanin in the skin, and it also can reduce the sun's ultraviolet.

The benifits of the Melanotan I/MT - I

The side effects associated with Melanotan I are similar to other peptides:  flushed face, headache, feeling dizzy, lethargy, nausea, white patches and possible soreness or redness at site of injection.  The benefits users get from Melanotan I are: darker skin pigmentation, appetite suppression, fat loss, lean body mass, increased libido and frequency of erections.

There is a serious anecdotal note about Melanotan I, some users have experienced serious nausea after using M2.  This is variable from user to user, but has to be a concern.  You need to feel out your dosages and start slow before you go head long into using this peptide.

Description

MT-1 (or Melanotan I, or Afamelanotide, or CUV-1647) is a synthetic analog of peptides nature of endogenous melanocortin peptide alpha-melanocyte stimulating hormone. It has hormones nature as well as common proteins features, its molecular weight/mass is 1646.88 and its molecular formula is C78H111N21O19. 
 
Afamelanotide was specifically developed by American scientists LED by V. Hruby in 1991 as a possible research compound that can be used against skin cancer by stimulating tanning system which in own turn would generate protective natural tan during melanogenesis. So that synthetic analog was created to determine if it can show the same effect and stimulate melanocytes to produce and release melanin to protect skin from UV. Most of studies and trials were conducted in United States and Australia. 
 
Developed research compound is quite stable cyclic form of original hormone but specifically has much longer half-life period. It works as agonist of specific melanocortin receptor and possesses such property as being selective. And thus it promotes increased level of eumelanin above usual pheomelanin, which provides higher efficacy of photoprotection abilities.

Related products